‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease
While this new treatment is “helpful” in some ways, “this is certainly not going to be the silver bullet that is going to resolve the issues of dementia,” said Dr. Samir Sinha, Sinha, director of health policy research at the National Institute on Ageing.